Cosmetic Evaluation of a Biomimetic Lamellar Serum Containing Oleyl Adapalenate for Acne-Prone Skin: An Exploratory Pilot Study

Adapalene is a well-established topical acne treatment, but its use may be limited by irritation, particularly in sensitive skin. Oleyl adapalenate (OA), a lipid-conjugated adapalene derivative, has demonstrated cosmetic efficacy in photoaged skin; however, clinical evidence in acne-prone skin remains limited. This study evaluated the clinical performance and tolerability of a biomimetic lamellar serum containing OA, supported by analytical characterization. The finished formulation exhibited antibacterial activity against Cutibacterium acnes (ATCC 6919), achieving a ≥5.2-log reduction in viability. LC-MS/MS detected OA in the finished formulation, and 1H-NMR analysis showed signals consistent with an oleyl adapalenate-type structure. A 4-week, single-arm, open-label pilot study was conducted in 20 participants with mild-to-moderate acne-prone skin. The serum was applied twice daily throughout the study period. After four weeks, favorable within-subject changes were observed in acne-related and skin barrier-associated measures using Holm–Bonferroni-adjusted statistical significance reported for the specified parameters, including non-inflammatory lesion counts (19.3%), inflammatory lesions (57.2%), Acne Severity Index (ASI) (31.6%), sebum-covered area (87.1%), Investigator’s Global Assessment (IGA) scores (36.7%), and trans-epidermal water loss (TEWL) (11.2%), along with increased stratum corneum hydration (13.6%). No irritation was observed in either the 24 h primary irritation patch test or during the 4-week clinical evaluation, suggesting favorable tolerability of the OA-containing formulation. These findings suggest that the OA-containing formulation may improve acne-related skin parameters and skin barrier-associated measures while demonstrating favorable skin tolerability without observable irritation. However, because the study was exploratory and lacked vehicle- and ingredient-specific controls, further randomized, blinded, controlled studies are required to confirm these findings.

Authors

Institutions

Publication Details

Journal
Cosmetics
Published
2026-11-16
DOI
https://doi.org/10.3390/cosmetics13060318
Primary Topic
Acne and Rosacea Treatments and Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cosmetic Evaluation of a Biomimetic Lamellar Serum Containing Oleyl Adapalenate for Acne-Prone Skin: An Exploratory Pilot Study

Gaewon Nam, Changmin Sung, Sekyoo Jeong, Yeojeong Cho et al.
Cosmetics
Acne and Rosacea Treatments and Effects
article

Cosmetic Evaluation of a Biomimetic Lamellar Serum Containing Oleyl Adapalenate for Acne-Prone Skin: An Exploratory Pilot Study

Gaewon Nam, Changmin Sung, Sekyoo Jeong, Yeojeong Cho, Byeong Deog Park, Yerim Kim
article en

Abstract

Adapalene is a well-established topical acne treatment, but its use may be limited by irritation, particularly in sensitive skin. Oleyl adapalenate (OA), a lipid-conjugated adapalene derivative, has demonstrated cosmetic efficacy in photoaged skin; however, clinical evidence in acne-prone skin remains limited. This study evaluated the clinical performance and tolerability of a biomimetic lamellar serum containing OA, supported by analytical characterization. The finished formulation exhibited antibacterial activity against Cutibacterium acnes (ATCC 6919), achieving a ≥5.2-log reduction in viability. LC-MS/MS detected OA in the finished formulation, and 1H-NMR analysis showed signals consistent with an oleyl adapalenate-type structure. A 4-week, single-arm, open-label pilot study was conducted in 20 participants with mild-to-moderate acne-prone skin. The serum was applied twice daily throughout the study period. After four weeks, favorable within-subject changes were observed in acne-related and skin barrier-associated measures using Holm–Bonferroni-adjusted statistical significance reported for the specified parameters, including non-inflammatory lesion counts (19.3%), inflammatory lesions (57.2%), Acne Severity Index (ASI) (31.6%), sebum-covered area (87.1%), Investigator’s Global Assessment (IGA) scores (36.7%), and trans-epidermal water loss (TEWL) (11.2%), along with increased stratum corneum hydration (13.6%). No irritation was observed in either the 24 h primary irritation patch test or during the 4-week clinical evaluation, suggesting favorable tolerability of the OA-containing formulation. These findings suggest that the OA-containing formulation may improve acne-related skin parameters and skin barrier-associated measures while demonstrating favorable skin tolerability without observable irritation. However, because the study was exploratory and lacked vehicle- and ingredient-specific controls, further randomized, blinded, controlled studies are required to confirm these findings.

CosmeticsVol. 13(6)
Yonsei University (KR), Komipharm International (South Korea) (KR), Korea Institute of Science and Technology (KR)
Good health and well-being
Acne and Rosacea Treatments and Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon